SAREUM HOLDINGS PLC ORD GBP 0.0吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
17 0 公告 Exercise of Warrants SAREUM HOLDINGS 资讯 08-26 14:45
21 0 公告 Exercise of Warrants SAREUM HOLDINGS 资讯 08-20 17:05
22 0 公告 Sareum Collaboration with Receptor.AI SAREUM HOLDINGS 资讯 08-12 15:04
28 0 公告 Exercise of Warrants SAREUM HOLDINGS 资讯 07-09 14:21
28 0 公告 Appointment of Sole Broker SAREUM HOLDINGS 资讯 07-04 14:19
37 0 公告 Initiation of Toxicology Studies for SDC-1801 SAREUM HOLDINGS 资讯 05-29 14:20
33 0 公告 Update on TYK2/JAK1 and SRA737 Programmes SAREUM HOLDINGS 资讯 04-28 14:14
33 0 公告 Exercise of Warrants SAREUM HOLDINGS 资讯 04-24 14:14
37 0 公告 Director’s Dealing SAREUM HOLDINGS 资讯 03-27 15:29
43 0 公告 Sareum Half-Year Report SAREUM HOLDINGS 资讯 03-25 15:12
51 0 公告 Notice of HY Results and Investor Presentation SAREUM HOLDINGS 资讯 03-20 15:24
34 0 公告 Sareum Acquires Licence for SRA737 SAREUM HOLDINGS 资讯 03-13 15:44
58 0 公告 Institutional Equity Fundraise SAREUM HOLDINGS 资讯 03-13 15:40
97 0 公告 Update on SRA737 SAREUM HOLDINGS 资讯 12-31 15:09
100 0 公告 Results of AGM SAREUM HOLDINGS 资讯 12-20 00:21
65 0 公告 AGM Statement SAREUM HOLDINGS 资讯 12-19 15:16
117 0 公告 Appointment of Joint Broker SAREUM HOLDINGS 资讯 12-18 16:04
82 0 公告 Holding(s) in Company SAREUM HOLDINGS 资讯 12-17 17:21
96 0 公告 Award of Share Options SAREUM HOLDINGS 资讯 12-16 15:09
98 0 公告 Notice of AGM, Annual Report and Accounts SAREUM HOLDINGS 资讯 11-27 17:41
86 0 公告 Final Results for the Year Ended 30 June 2024 SAREUM HOLDINGS 资讯 10-29 15:08
104 0 公告 Notice of Final Results and Investor Presentation SAREUM HOLDINGS 资讯 10-23 14:14
75 0 公告 Further Subscription to raise £1,000,000 SAREUM HOLDINGS 资讯 10-21 14:26
79 0 公告 Subscription to raise £2,364,000 SAREUM HOLDINGS 资讯 10-11 14:14
105 0 公告 Patent Allowance in China SAREUM HOLDINGS 资讯 09-16 14:20
94 0 公告 US patent allowance SAREUM HOLDINGS 资讯 09-02 14:16
90 0 公告 Management Changes SAREUM HOLDINGS 资讯 07-10 15:08
86 0 公告 Positive Data from SDC-1801 Phase 1 Clinical Trial SAREUM HOLDINGS 资讯 07-01 17:58
85 0 公告 Appointment of Sole Broker SAREUM HOLDINGS 资讯 05-30 15:20
70 0 公告 Exercise of Warrants SAREUM HOLDINGS 资讯 05-07 22:13
70 0 公告 Final Issue of RiverFort Subscription Shares SAREUM HOLDINGS 资讯 04-23 15:08
86 0 公告 Issue of RiverFort Subscription Shares SAREUM HOLDINGS 资讯 04-19 19:43
86 0 公告 Issue of RiverFort Subscription Shares SAREUM HOLDINGS 资讯 04-15 23:33
63 0 公告 Issue of RiverFort Subscription Shares SAREUM HOLDINGS 资讯 04-10 00:18
92 0 公告 Completion of Equity Fundraise SAREUM HOLDINGS 资讯 04-04 22:42
71 0 公告 Result of WRAP Retail Offer SAREUM HOLDINGS 资讯 04-03 00:59
72 0 公告 Increase in size of WRAP Retail Offer SAREUM HOLDINGS 资讯 04-02 15:17
79 0 公告 WRAP Retail Offer SAREUM HOLDINGS 资讯 03-28 16:24
83 0 公告 Equity Fundraise SAREUM HOLDINGS 资讯 03-28 16:13
68 0 公告 Sareum Half-Year Report SAREUM HOLDINGS 资讯 03-28 16:09
71 0 公告 New Patent Allowance SAREUM HOLDINGS 资讯 03-15 16:04
74 0 公告 Notice of Interim Results and Trading Update SAREUM HOLDINGS 资讯 03-12 22:37
87 0 公告 Update on SDC-1801 Clinical Trial Progress SAREUM HOLDINGS 资讯 02-15 16:08
91 0 公告 Development and commercialisation licence SRA737 SAREUM HOLDINGS 资讯 01-02 16:11
115 0 公告 Results of AGM SAREUM HOLDINGS 资讯 12-15 00:44
133 0 公告 Annual General Meeting Statement SAREUM HOLDINGS 资讯 12-14 16:10
95 0 公告 Drawdown of Equity Prepayment Facility SAREUM HOLDINGS 资讯 11-23 16:10
96 0 公告 Notice of AGM, Annual Report and Accounts SAREUM HOLDINGS 资讯 11-21 16:08
71 0 公告 Initiation of food effects study for SDC-1801 SAREUM HOLDINGS 资讯 11-09 16:13
97 0 公告 Director Dealings SAREUM HOLDINGS 资讯 11-09 00:22
96 0 公告 Sareum enhances SDC-1801 patent protection SAREUM HOLDINGS 资讯 11-03 16:12
99 0 公告 Exercise of Share Options and Director Dealings SAREUM HOLDINGS 资讯 11-02 23:57
96 0 公告 Final Results for the Year Ended 30 June 2023 SAREUM HOLDINGS 资讯 10-09 15:02
81 0 公告 Notice of Results and Investor Presentation SAREUM HOLDINGS 资讯 10-03 15:09
108 0 公告 Director's Dealing SAREUM HOLDINGS 资讯 09-06 15:04
79 0 公告 Director Dealing SAREUM HOLDINGS 资讯 09-05 15:09
99 0 公告 Dosing of first subjects in MAD Phase 1a trial SAREUM HOLDINGS 资讯 09-04 15:10
85 0 公告 Update on financial and operational progress SAREUM HOLDINGS 资讯 08-16 15:10
116 0 公告 Equity Prepayment Facility of up to £5 million SAREUM HOLDINGS 资讯 08-03 15:04
77 0 公告 Sareum Announces Two New Granted Patents SAREUM HOLDINGS 资讯 06-26 15:03
100 0 公告 Dosing commences in Phase 1a trial of SDC-801 SAREUM HOLDINGS 资讯 06-06 15:16
134 0 公告 Phase 1a clinical trial for SDC-1801 SAREUM HOLDINGS 资讯 05-18 15:14
130 0 公告 Approval to initiate Phase 1 clinical trial SAREUM HOLDINGS 资讯 05-05 17:36
125 0 公告 Half-Year Report SAREUM HOLDINGS 资讯 03-22 16:15
127 0 公告 Notice of Half-Year Results SAREUM HOLDINGS 资讯 03-15 16:09
114 0 公告 Update on SDC-1801 SAREUM HOLDINGS 资讯 03-15 16:08
151 0 公告 Update on SRA737 SAREUM HOLDINGS 资讯 03-06 16:09
139 0 公告 Director/PDMR Shareholding SAREUM HOLDINGS 资讯 12-30 00:19
226 0 公告 Results of AGM SAREUM HOLDINGS 资讯 12-17 00:37
139 0 公告 AGM Statement SAREUM HOLDINGS 资讯 12-16 16:18
131 0 公告 Notice of AGM, Annual Report and Accounts SAREUM HOLDINGS 资讯 11-24 16:14
169 0 公告 Sareum notes publication of SRA737 clinical data SAREUM HOLDINGS 资讯 11-21 15:07
160 0 公告 Second Price Monitoring Extn SAREUM HOLDINGS 资讯 11-10 01:53
138 0 公告 Price Monitoring Extension SAREUM HOLDINGS 资讯 11-10 01:39
116 0 公告 Price Monitoring Extension SAREUM HOLDINGS 资讯 11-09 23:10
138 0 公告 Second Price Monitoring Extn SAREUM HOLDINGS 资讯 11-09 23:10
132 0 公告 Price Monitoring Extension SAREUM HOLDINGS 资讯 11-09 20:11
136 0 公告 Second Price Monitoring Extn SAREUM HOLDINGS 资讯 11-09 20:11
122 0 公告 Second Price Monitoring Extn SAREUM HOLDINGS 资讯 11-09 18:10
125 0 公告 Price Monitoring Extension SAREUM HOLDINGS 资讯 11-09 18:10
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
温馨提示: 1.根据《证券法》规定,禁止编造、传播虚假信息或者误导性信息,扰乱证券市场;2.用户在本社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500